Clinical Trial Update: Smartguard Use in Real Life : a Longitudinal Study in Patients With Type 1 Diabetes

View source ↗

Summary

A longitudinal study evaluating Smartguard use in real-life management of Type 1 Diabetes Mellitus has completed (NCT03047486).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University Hospital, Caen | Conditions: Type 1 Diabetes Mellitus Maturity Onset | Status: COMPLETED